Skip to content
NewsBlazeIN – Lifestyle
Author:
Polaryx Therapeutics, Inc.
Polaryx Therapeutics Activates First Clinical Trial Site for SOTERIA Phase 2 Basket Trial of PLX-200
November 9, 2026
Polaryx Therapeutics Appoints Dr. Will Charlton as Chief Medical Officer
September 1, 2026
Polaryx Therapeutics Advances Operational Readiness for SOTERIA Phase 2 Basket Trial
August 25, 2026
Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial
May 28, 2026
Polaryx Therapeutics Receives GHP Magazine’s Healthcare & Pharmaceuticals Awards
May 14, 2026